The Innovator - AC Immune’s Quest To Make Alzheimer’s Disease Preventable
The number of people with dementia is predicted to more than triple to 152 million by 2050. The cost of caring for these patients is expected to double to $2 trillion in the next eight years alone.
Building on nearly 20 years of research and development in neurodegenerative diseases, AC Immune CEO Andrea Pfeifer is convinced that early diagnosis and prevention of neurodegenerative diseases through vaccines, could effectively tackle this silent pandemic.
This article is being displayed with the permission of The Innovator, (www.theinnovator.news) a subscription publication about innovation.
Click to sign up for a free-four week trial.